dvax stock forecast zacks

If a stocks EPS consensus estimate is 110 now vs. Plus the company is currently a Zacks Rank 1 Strong Buy stock suggesting that DVAX could be.


Analysts Just Shipped A Dazzling Upgrade To Their Dynavax Technologies Corporation Nasdaq Dvax Estimates

You can see the complete list of todays Zacks 1 Rank Strong Buy.

. 100 the week before. The mean of analysts price targets for Dynavax Technologies DVAX points to a 2101 upside in the stock. Regeneron Vertex Pharmaceuticals Dynavax Technologies Corp.

This compares to earnings of 006. View Dynavax Technologies Corporation DVAX investment stock information. DVAX is currently holding a Zacks Rank of 2 Buy and a Value grade of A.

The stock holds a PE ratio of 2051 while its industry has an average PE of 5622. This compares to its industrys average Forward PE of. Based on 3 Wall Street analysts offering 12 month price targets for Dynavax in the last 3 months.

Based on short-term price targets offered by four analysts the average price target for Dynavax Technologies comes to 2950. By Zacks Equity Research Published on October 212022. This has helped DVAX to earn a Zacks Rank 2 Buy further underscoring the companys solid position.

DVAX is currently sporting a Zacks Rank of 2 Buy as well as an A grade for Value. Dynavax Technologies DVAX came out with quarterly earnings of 043 per share beating the Zacks Consensus Estimate of 033 per share. The forecasts range from a low of 2200 to a.

Dynavax Technologies discovers develops and intends to commercialize innovative products to treat and prevent allergies infectious diseases and. The stock is trading with a PE ratio of 3738 which compares to its industrys average of. The 5 analysts offering 12-month price forecasts for Dynavax Technologies Corp have a median target of 2400 with a high estimate of 3000 and a low estimate of 2000.

The stock has a Forward PE ratio of 2397. Zacks Investment Research Oct 24 2022 Dynavax Technologies DVAX Crossed Above the 20-Day Moving Average. Our experts picked 7 Zacks Rank 1 Strong Buy stocks with the best chance to skyrocket within the next 30-90 days.

What That Means for Investors Zacks Investment Research. Zacks Industry Outlook Highlights. See Dynavax Technologies Corporation stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy.

Recent stocks from this report have soared up to. Get the latest Dynavax Technologies Corporation DVAX detailed stock quotes stock data Real-Time ECN. Weather Underground provides local long-range.

Find the latest Dynavax Technologies Corporation DVAX stock quote history news and other vital information to help you with your stock trading and investing. DVAX Stock Price Prediction. The average price target is 2367 with a high forecast of 2800.

Find the latest Dynavax Technologies Corporation DVAX stock discussion in Yahoo Finances forum. And Repligen Entrepreneur 232022 Dynavax Technologies Corp DVAX. DVAX is currently sporting a Zacks Rank of 2 Buy as well as a Value grade of A.

Shares of DVAX have been moving higher over the past four weeks up 73. Share your opinion and gain insight from other stock traders and investors. Web DVAX Complete Dynavax Technologies Corp.


Buy Dynavax Technologies Stock Dvax Stock Price Today News Public Com


Encompass Health Ehc Piedmont Tie Up To Better Serve Georgia Nasdaq


Nex Nextier Oilfield Solutions Comparative Chart Zacks Com


Earnings Calendar Zacks Investment Research


Dynavax Technologies Nasdaqcm Dvax Share Price News Analysis Simply Wall St


Zacks Com E Commerce Log In


Dvax Dynavax Technologies Corp Stock Overview U S Nasdaq Barron S


Abbv Abbvie Comparative Chart Zacks Com


Mod Modine Manufacturing Comparative Chart Zacks Com


Should I Buy Chinese Internet Stocks Now


Qhvuejn9wmceum


Dynavax Technologies Stock Full Speed Ahead Nasdaq Dvax Seeking Alpha


Does Dynavax Technologies Dvax Have The Potential To Rally 210 As Wall Street Analysts Expect October 21 2022 Zacks Com


Most Recent Articles Zacks Com


Novartis Nvs Q3 Earnings Top Revenues Miss Estimates Nasdaq


Aioi86qj3owzxm


Aioi86qj3owzxm


Dvax Dynavax Technologies Corp Stock Overview U S Nasdaq Barron S


Provention Prvb Up On Deal With Sanofi For Diabetes Drug Nasdaq

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel